Pages

Thursday, 8 September 2022

FDA warns of potential clip lock issue with Abbott's heart valve repair device

FDA warns of potential clip lock issue with Abbott's heart valve repair device

The U.S. Food and Drug Administration on Thursday alerted healthcare providers about a potential clip lock issue with Abbott Laboratories' MitraClip device used to stop heart valve leakage.

FDA receives reports of cancer linked to breast implants

The U.S. Food and Drug Administration has received several reports of certain types of cancers in the scar tissue that forms around breast implants, the agency said in a safety notice on Thursday.

U.S. orders 100 million COVID tests, White House says more needed

The United States will boost its stockpile of at-home COVID-19 tests, ordering more than 100 million tests from domestic manufacturers, the White House said on Thursday, but warned it was a short-term solution.

U.S. COVID vaccine market could reach $13 bln -Moderna exec

The annual U.S. COVID-19 vaccine market going forward could be in the range of $5.2 billion to $12.9 billion, depending on the price of shots and who is eligible to receive them, Moderna Inc's chief commercial officer said on Thursday.

U.S. starts enrollments in trial testing smaller dosage of monkeypox vaccine

The National Institutes of Health said on Thursday it had started enrollments in a trial testing an alternative method of administering Bavarian Nordic's monkeypox vaccine, Jynneos, which requires smaller dosages.

Newsletter H236 x W452.png
Sponsored by Roche: Where you live should not determine if you live

Our panel, featuring Apl.De.AP, Dr Ratna Devi and Muniba Mazari engaged in a lively discussion on improving access to healthcare in Asia

Watch our LifeTalk now!

Bayer, Regeneron's eye drug shown to work at higher dose, longer intervals

Bayer said on Thursday its anti-blindness treatment Eylea, jointly developed with Regeneron , has been shown to work as well when given at a higher dose at a longer interval between injections.

Botox rival from Revance gets U.S. approval

The U.S. Food and Drug Administration on Thursday approved Revance Therapeutics' anti-wrinkle injection, setting up a challenger for market leader AbbVie's Botox that has long dominated the aesthetic market.

Long COVID's link to suicide: scientists warn of hidden crisis

Several scientists are beginning to study a potential link following evidence of increased cases of depression and suicidal thoughts among people with long COVID.

Millions in China's Chengdu thrown into extended COVID lockdown

Chengdu extended a lockdown for a majority of its more than 21 million residents to prevent further transmission of COVID while millions more in other parts of China were told to shun holiday travel.

Gambia probes link between dozens of child deaths and paracetamol syrup

Gambia's government is investigating whether the deaths of dozens of young children from kidney failure in recent months are linked to paracetamol syrup, the head of the country's health service said on Thursday.

Related Videos

Millions locked-down in Shenzen over COVID fears

FDA approves Omicron-targeting booster shots

Authorities ramp up Shenzhen COVID curbs